1. A Review of Safety-Related Pregnancy Data Surrounding the Oral Disease-Modifying Drugs for Multiple Sclerosis

   • Ellen Lu
   • Bing Wei Wang
   • Helen Tremlett

   Current Opinion 17 December 2013 Pages: 89 - 94

2. Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders

   • Erin A. McClure
   • Cassandra D. Gipson
   • Kevin M. Gray

   Leading Article 18 January 2014 Pages: 95 - 106

   

3. Combined Pharmacotherapies for the Management of Alcoholism: Rationale and Evidence to Date

   • Mary R. Lee
   • Lorenzo Leggio

   Leading Article 05 February 2014 Pages: 107 - 119

4. Attention-Deficit/Hyperactivity Disorder with Inadequate Response to Stimulants: Approaches to Management

   • Ann C. Childress
   • Floyd R. Sallee

   Therapy in Practice 09 January 2014 Pages: 121 - 129

   

5. Neurological and Psychiatric Adverse Effects of Antiretroviral Drugs

   • Michael S. Abers
   • Wayne X. Shandera
   • Joseph S. Kass

   Review Article 21 December 2013 Pages: 131 - 145

6. Clinical Relevance of Brain Volume Measures in Multiple Sclerosis

   • Nicola De Stefano
   • Laura Airas
   • Bernd C. Kieseier

   Review Article 22 January 2014 Pages: 147 - 156

7. A 2-Year Prospective Cohort Study of Antidementia Drug Non-Persistency in Mild-to-Moderate Alzheimer's Disease in Europe

   • Virginie Gardette
   • Maryse Lapeyre-Mestre
   • The ICTUS Group

   Original Research Article 10 January 2014 Pages: 157 - 170

   

8. Aripiprazole: A Review of Its Use in the Treatment of Manic Episodes in Adolescents with Bipolar I Disorder

   • Kate McKeage

   Adis Drug Evaluation 08 January 2014 Pages: 171 - 183